Concorde Financial’s Oracle ORCL Stock Holding History

Concorde Financial’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-179	Closed	-$16K	–	110
2021 Q4	$16K	Buy	+179	New	+$16.8K	0.01%	86

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Concorde Financial's ORCL Position: Q1 2022 in Review

Concorde Financial sold out of Oracle (ORCL) in Q1 2022, closing a stake of 179 shares — an estimated $16K sold.

Concorde Financial first reported a position in ORCL in Q4 2021 and held it in 1 quarter. The position peaked at $16K in Q4 2021. 2,266 funds tracked by Wall St. Rank hold ORCL as of Q1 2022.

Concorde Financial reported no remaining Oracle position as of Q1 2022 after selling out during the quarter.
Concorde Financial sold 179 Oracle shares in Q1 2022, an estimated $16K.
Concorde Financial first reported a position in Oracle in Q4 2021 and held it in 1 quarter.
Concorde Financial's Oracle position peaked at $16K in Q4 2021.
2,266 funds tracked by Wall St. Rank held Oracle as of Q1 2022.

Based on Concorde Financial's 13F filing for Q1 2022, filed 16 May 2022.